// App-Quantinova.ai

896 : Hydroxychloroquine Use and Cardiovascular Events Among Patients with Systemic Lupus Erythematosus and Rheumatoid Arthritis

Researchers

Presenter

  • Na Lu

Principal Investigators

  • Hyon K. Choi

  • John Esdaile

  • Diane Lacaille

  • J. Antonio Avina-Zubieta

Medical Centers

  • Massachusetts General Hospital, Boston, MA

  • Massachusetts General Hospital, Boston, MA

  • Arthritis Research Centre, University of British Columbia, Richmond,Canada

  • Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada

  • Arthritis Research Canada / University of British Columbia, Vancouver, BC, Canada

Locations

  • United States

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

  • Autoimmune (AI)

  • Nephrology

  • Central Nervous System (CNS)

  • Pulmonary/Respiratory Diseases

Disease

  • Lupus

  • Transient Ischemic Attack

  • Transient ischemic attack

  • Chronic kidney disease

  • Venous thrombosis

  • Myocardial infarction

  • Rheumatoid arthritis

  • Deep vein thrombosis

  • Pulmonary embolism

  • Renal disease

  • Inflammatory Arthritis

  • Stroke

Biomarkers

  • N/A

Drug/Treatment

  • Hydroxychloroquine

  • Glucocorticoid

Outcome

  • N/A


Study Design

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A